| Literature DB >> 30850029 |
Hitoshi Takamatsu1, Ken-Ichi Yamamoto1, Nahoko Tomonobu1, Hitoshi Murata1, Yusuke Inoue2, Akira Yamauchi3, I Wayan Sumardika1, Youyi Chen1, Rie Kinoshita1, Masahiro Yamamura4, Hideyo Fujiwara5, Yosuke Mitsui1, Kota Araki1, Junichiro Futami6, Ken Saito7, Hidekazu Iioka7, I Made Winarsa Ruma8, Endy Widya Putranto9, Masahiro Nishibori10, Eisaku Kondo7, Yasuhiko Yamamoto11, Shinichi Toyooka12, Masakiyo Sakaguchi1.
Abstract
The fertile stroma in pancreatic ductal adenocarcinomas (PDACs) has been suspected to greatly contribute to PDAC progression. Since the main cell constituents of the stroma are fibroblasts, there is crosstalking(s) between PDAC cells and surrounding fibroblasts in the stroma, which induces a fibroblast proliferation burst. We have reported that several malignant cancer cells including PDAC cells secrete a pronounced level of S100A11, which in turn stimulates proliferation of cancer cells via the receptor for advanced glycation end products (RAGE) in an autocrine manner. Owing to the RAGE+ expression in fibroblasts, the extracellular abundant S100A11 will affect adjacent fibroblasts. In this study, we investigated the significance of the paracrine axis of S100A11-RAGE in fibroblasts for their proliferation activity. In in vitro settings, extracellular S100A11 induced upregulation of fibroblast proliferation. Our mechanistic studies revealed that the induction is through RAGE-MyD88-mTOR-p70 S6 kinase upon S100A11 stimulation. The paracrine effect on fibroblasts is linked mainly to triggering growth but not cellular motility. Thus, the identified pathway might become a potential therapeutic target to suppress PDAC progression through preventing PDAC-associated fibroblast proliferation.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30850029 DOI: 10.3727/096504018X15433161908259
Source DB: PubMed Journal: Oncol Res ISSN: 0965-0407 Impact factor: 5.574